CP-724714

AdipoGen Life Sciences
Product Code: SYN-1033
CodeSizePrice
SYN-1033-M100100 mgEnquire
Quantity:
SYN-1033-M0011 mg£104.00
Quantity:
SYN-1033-M0055 mg£162.00
Quantity:
SYN-1033-M01010 mg£268.00
Quantity:
SYN-1033-M05050 mg£848.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
-20°C

Images

1 / 1
Chemical Structure

Chemical Structure

Further Information

Alternate Names/Synonyms:
CP724714
Appearance:
Solid.
CAS:
383432-38-0
EClass:
32160000
Form (Short):
liquid
InChi:
InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+
InChiKey:
LLVZBTWPGQVVLW-SNAWJCMRSA-N
Long Description:
Chemical. CAS: 383432-38-0. Formula: C27H27N5O3. MW: 469.5. CP-724714 is an oral, selective and potent ErbB-2 (HER2) kinase inhibitor with an IC(50) of 10 nM. It has >640-fold selectivity for ErbB-2 (HER2) over EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, c-Met.
Molecular Formula:
C27H27N5O3
Molecular Weight:
469.5
Package Type:
Plastic Vial
Product Description:
CP-724714 is an oral, selective and potent ErbB-2 (HER2) kinase inhibitor with an IC(50) of 10 nM. It has >640-fold selectivity for ErbB-2 (HER2) over EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, c-Met.
Purity:
>95%
Solubility Chemicals:
Soluble in DMSO or ethanol.
Transportation:
Non-hazardous
UNSPSC Category:
Protein Kinase Modulators
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.

References

Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor: J.P. Jani, et al.; Cancer Res. 67, 9887 (2007)

Related Products

Product NameProduct CodeSupplier 
JNJ-38877605SYN-1047AdipoGen Life Sciences Summary Details
AMG-51SYN-1111AdipoGen Life Sciences Summary Details
AMG-1SYN-1143AdipoGen Life Sciences Summary Details
AMG-458SYN-1144AdipoGen Life Sciences Summary Details
MK-2461SYN-1149AdipoGen Life Sciences Summary Details